文献速递临床试验与 GCP流行病学与生物统计

外科重症监护室受血者生存与献血者年龄的关联:多中心随机对照试验研究方案

Association between recipient survival and blood donor age after blood transfusion in a surgery intensive care unit: a multicenter randomized controlled trial study protocol.
PubMed 文献 · Trials · 2020-07-08

本研究为一项多中心随机对照试验方案,旨在评估外科重症监护室患者接受不同年龄男性献血者血液制品后的生存预后。患者随机分为三组,分别接受<25岁、25-45岁及>45岁献血者的血液制品,主要观察28天生存时间。

要点

  • 探讨献血者年龄对重症外科患者输血后28天生存的影响。
  • 采用实用型多中心随机开放平行对照优效性试验设计。
  • 按献血者年龄<25、25-45、>45岁分组比较生存差异。

核心结论

  • 本方案提供了一种可行的随机对照试验设计,用于评估不同年龄献血者血液制品对重症外科患者预后的影响。

研究设计与样本

  • 多中心、开放、平行组、非盲法、优效性随机对照试验。
  • 招募外科重症监护室患者,随机分为三组,分别接受<25岁、25-45岁和>45岁男性献血者的血液制品。

关键数值与推荐

  • 主要观察指标为28天内的生存时间。
  • 采用Kaplan-Meier分析、双因素方差分析和Cox比例风险模型进行统计分析。
  • 试验注册号:ChiCTR190002,注册日期2019年3月22日。

临床怎么用

  • 该研究方案可为输血相关临床决策提供随机对照证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Blood from younger individuals has been shown to improve physiological function in recipients in laboratory research, and many proteins from human peripheral blood show antisenescence capabilities. Thus, researchers have questioned whether blood from young donors is superior to blood from older donors. Blood transfusion is a key supportive therapy for trauma patients, and recent studies have reported the influence of blood donor age on recipient patient prognosis. Although some retrospective results found that blood from young donors improves survival, no influence of blood donor age was observed on outcomes in other study groups. The reasons for this discrepancy are complicated, but the fact that data were not obtained from randomized controlled trial (RCT) data should be considered. The current protocol and analysis method provide a feasible RCT design to evaluate the prognosis of severely ill surgery patients who were transfused with blood products from blood donors of different ages. METHODS: The current study is a pragmatic multicenter RCT (open, parallel-group, non-masked, superiority trial). Recruited surgery intensive care unit patients will be randomized into three groups and transfused with blood products from male donors of different ages (< 25, 25-45, and > 45 years). Survival time will be measured within 28 days. The survival characteristics, possible interaction between variables, and potential factors associated with death will be analyzed by Kaplan-Meier analysis, two-way ANOVA, and Cox proportional hazards model, respectively. TRIAL REGISTRATION: ChiCTR: ChiCTR190002. Registered on 22 March 2019. http://www.chictr.org.cn/showproj.aspx?proj=36867 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zeng X, Liao Y, Wu X, et al. Association between recipient survival and blood donor age after blood transfusion in a surgery intensive care unit: a multicenter randomized controlled trial study protocol. Trials. 2020. PMID: 32641079. doi:10.1186/s13063-020-04452-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。